Hyper-responsiveness to warfarin in a young patient with the vkorc1 -1639ga/cyp2c9*1*46 genotype: a case report

HIGHLIGHTS

• who: Weam Aldiban from the (UNIVERSITY) have published the research: Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report, in the Journal: (JOURNAL)
• what: The authors report a case of warfarin hyper-responsiveness, manifested by above the therapeutic range INR (i.e., a supratherapeutic INR) in response to standard warfarin doses in a young man in his twenties with a history of CD managed by sulfasalazine and azathioprine.

SUMMARY

Inter-individual variations in dose requirements that ensure the stability of anticoagulation . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.